Indiana’s Role in the Alzheimer’s Battle:

Alzheimer’s disease has disrupted and devastated families for decades. Researchers in Indiana and around the world have sought solutions to one of our most vexing medical conditions, and real progress is being made. Indiana’s role is significant and our hosts will set the stage for an important discussion.

• Melina Kennedy, CEO, Central Indiana Corporate Partnership
• Dan Peterson, Chairman, BioCrossroads
• Phyllis Ferrel, Consultant and Advocate, Alzheimer’s Disease and Brain Health

Alzheimer’s presents numerous challenges for people living with the disease and their families alike, including financial, physical, social, disease progression, and – historically – a lack of treatment options. Our panel will unveil the issues faced by families and underscore what progress would look like, including recent successes in Indiana and elsewhere.

Moderator:

• Phyllis Ferrel, Consultant and Advocate, Alzheimer’s Disease and Brain Health

Panelists:

• Maria Carrillo, Chief Science Officer, the Alzheimer’s Association
• John Dwyer, President, Global Alzheimer’s Platform Foundation
• Natalie Sutton, Chapter Executive, Alzheimer’s Association of Indiana
• Jared Brosch, Associate Professor, Indiana University School of Medicine

Breakthroughs are on the horizon. Biopharmaceutical companies, leading research universities, and newer biotech companies are driving scientific innovation that could make a difference for people everywhere. How are Indiana life sciences organizations driving meaningful change?

Keynote Remarks (10:35-11:00 AM)

• Bruce Lamb, Executive Director, Stark Neuroscience Research Institute, Indiana University School of Medicine

Panel Discussion: Near-Term Hope for the Community (11:00-11:45 AM)

Moderator:

• Kylie Veleta, Inside Indiana Business

Panelists:

• Bruce Lamb, Executive Director, Stark Neuroscience Research Institute, Indiana University School of Medicine
• Maria Carrillo, Chief Science Officer, the Alzheimer’s Association
• Dawn Brooks, Global Development Leader, Alzheimer’s, Eli Lilly and Company
• Jared Brosch, Associate Professor, Indiana University School of Medicine

Panel Discussion: Longer-Term Hope for the Community (11:45 AM-12:30 PM)

Moderator:

• Kylie Veleta, Inside Indiana Business

Panelists:

• Alan Palkowitz, President and CEO, Indiana Biosciences Research Institute
• Derek Small, Founding Managing Director, Luson Bioventures
• Cristian Lasagna-Reeves, Associate Professor at the Indiana University School of Medicine, Director of Neurodegenerative Disorders Research Group, Stark Neurosciences Research Institute
• Russ Barton, Chief Operating Officer, Acumen Pharmaceuticals

A diagnosis of Alzheimer’s is emotionally overwhelming with unknown hurdles ahead for people whose families haven’t experienced it. People living with the disease, their caregivers, advocacy groups, and others who understand the personal and medical burdens can articulate the emotions and how to cope with them.

A Conversation: Living with Alzheimer’s

• Natalie Sutton, Chapter Executive, Alzheimer’s Association of Indiana, who will talk to Darlene Bradley, an Indiana resident who lives with Alzheimer’s.

A Discussion: Helping People with Alzheimer’s and Their Families

Moderator:

• Natalie Sutton, Chapter Executive, Alzheimer’s Association of Indiana

Panelists:

• Karen Campbell, caregiver for her mother who lives with Alzheimer’s.
• Dustin Ziegler, Program Director focused on caregiver support and programming, Indiana PathWays to Aging Program, Anthem of Indiana
• Tina McIntosh, Founder, Joy’s House
• Kimberly Roop, President, Medicaid, Anthem of Indiana, and a caregiver for her mother who lived with Alzheimer’s.
  

Meaningful research is exciting but advancing beyond environmental challenges to improve lives is the goal. Our panel will discuss challenges such as reimbursement and access along policies, health equity, with the perspective of treating physicians.

Moderator:

• Kylie Veleta, Inside Indiana Business

Panelists:

• John Dwyer, President, Global Alzheimer’s Platform Foundation
  
• Brandy Matthews, Vice President, Global and US Medical Affairs, Eli Lilly and Company
• Laura Parnas, Disease Area Network Lead, Neurology and Cardiometabolism, Medical and Scientific Affairs, Roche Diagnostics U.S.
• Laurie Gutmann, Chair, Department of Neurology, Indiana University School of Medicine
• Jeff Dage, Senior Research Professor, Neurology, and Primary Member, Stark Neurosciences Research Institute, Indiana University School of Medicine

• Tatiana Foroud, Executive Associate Dean for Research Affairs, Indiana University School of Medicine